Reversal of Dabigatran with Idarucizumab in Acute Subarachnoid Hemorrhage

Dabigatran etexilate mesylate is a direct thrombin inhibitor used for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Dabigatran belongs to a new generation of oral agents for anticoagulation – the direct oral anticoagulants (DOACs). The DOACs als...

Descripción completa

Detalles Bibliográficos
Autores principales: Balakumar, Jonathan, Santiago, Ruben, Supino, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965212/
https://www.ncbi.nlm.nih.gov/pubmed/29849330
http://dx.doi.org/10.5811/cpcem.2017.6.34356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965212/
https://www.ncbi.nlm.nih.gov/pubmed/29849330
http://dx.doi.org/10.5811/cpcem.2017.6.34356

Ejemplares similares